# Safety and Tolerability of VGR-R01 in Patients With Bietti Crystalline Dystrophy

> **NCT05399069** · EARLY_PHASE1 · UNKNOWN · sponsor: **Beijing Tongren Hospital** · enrollment: 3 (estimated)

## Conditions studied

- Bietti Crystalline Dystrophy

## Interventions

- **DRUG:** VGR-R01

## Key facts

- **NCT ID:** NCT05399069
- **Lead sponsor:** Beijing Tongren Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-15
- **Primary completion:** 2024-05
- **Final completion:** 2024-05
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2022-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05399069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05399069, "Safety and Tolerability of VGR-R01 in Patients With Bietti Crystalline Dystrophy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05399069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*